Rituximab maintenance therapy in central nervous system lymphoma?

Leuk Lymphoma. 2009 Oct;50(10):1555-6. doi: 10.1080/10428190903254409.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / pharmacokinetics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Biological Availability
  • Central Nervous System Neoplasms / drug therapy*
  • Dacarbazine / administration & dosage
  • Dacarbazine / analogs & derivatives
  • Dose-Response Relationship, Drug
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Retrospective Studies
  • Rituximab
  • Salvage Therapy
  • Temozolomide

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Dacarbazine
  • Temozolomide